65.5 F
San Diego
Monday, Mar 18, 2024
-Advertisement-

Freedom Meditech Inc. Appoints John Gerace CEO

Medical-device maker Freedom Meditech Inc. announced Thursday that it has appointed John Gerace, most recently of Life Technologies, as its chief executive officer and a member of the company’s board of directors.

Gerace will oversee all company operations, build the management team and lead the company’s fundraising efforts to expand commercialization of the company’s FDA-cleared, noninvasive tool used by eye care professionals, the ClearPath DS-120, which measures autofluorescence in the eye, a possible early indicator of diabetes.

In his six years with Life Technologies, which was acquired by Thermo Fisher in 2014, Gerace had led the company’s Applied Sciences division and also served as vice president and general manager of the PCR Systems business unit.

Additionally, the company announced that it has raised $4.8 million in a Series C financing intended for general capital.

The company said in a release that since its 2006 founding, it has raised a total of $14 million in capital.

-Advertisement-

Featured Articles

Oberon Eyes Europe for Renewable DME

Leaders of Influence in Law 2024

-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-
-Advertisement-